Delivery Order SPE2DB20D7066-SPE2DB25FC2YE

Award Date 4/9/25
Potential Completion Date 4/10/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,089.80, is for the delivery of ISOTRETINOIN 40 MG CAPSULE 30S. It is a firm fixed-price delivery order contract that runs through March 12, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,304.77 firm fixed-price delivery order is for the supply of ISOTRETINOIN 30 MG CAPSULE 30S, a generic pharmaceutical product. The contract has an ultimate completion date of October 22, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,413.92 firm fixed-price delivery order is for the supply of ISOTRETINOIN 30 MG CAPSULE 30S, a prescription medication. The contract has an ultimate completion date of May 14, 2025. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,376.44 firm fixed-price delivery order is for the supply of ISOTRETINOIN 40 MG CAPSULE 30S, a pharmaceutical product, with a completion date of March 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,095.94 Firm Fixed Price Delivery Order contract is for the supply of ISOTRETINOIN 40 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of March 7, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,895.81 firm fixed-price delivery order is for the supply of ISOTRETINOIN 40 MG CAPSULE 10S, with a period of performance through November 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is a delivery order valued at $1,612.57, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The contract is for the delivery of ISOTRETINOIN 40 MG CAPSULE 30S, a prescription medication. The contract has a firm fixed price and an ultimate completion date of May 23, 2025. The contract is not set aside and was open to full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This federal contract award, valued at $2,444.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the provision of isotretinoin 40 mg capsules, with a completion date of May 1, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,229.28 firm-fixed-price delivery order is for the supply of 4,568,246,694 units of the medication isotretinoin 40 mg capsules. The contract is not set aside and has a period of performance extending through May 15, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,020.96 firm fixed-price delivery order is for the supply of Isotretinoin 40 mg capsules, a specialty pharmaceutical product. The contract has an ultimate completion date of October 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
  • SPE2DB20D7066
    Indefinite Delivery Contract
  • SPE2DB20D7066-SPE2DB25FC2YE
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,356.12 firm fixed-price delivery order is for the supply of ISOTRETINOIN 20 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of April 10, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

The contract award was not designated with any set-aside requirements, indicating open competition.

Generated 7/9/25, 9:52 AM